Monitoring minimal residual disease by ddPCR in acute lymphoblastic leukemia associated with the FGFR1 gene rearrangement

Int J Lab Hematol. 2018 Dec;40(6):e117-e120. doi: 10.1111/ijlh.12879. Epub 2018 Jun 28.

Authors

N Coccaro¹, G Tota¹, A Zagaria¹, L Anelli¹, P Casieri¹, L Impera¹, A Minervini¹, C F Minervini¹, P Orsini¹, C Cumbo¹, E Parciante¹, M Delia¹, C Brunetti¹, G Specchia¹, F Albano¹

Affiliation

¹ Hematology Section, Department of Emergency and Organ Transplantation (D.E.T.O.), University of Bari, Bari, Italy.

PMID: 29956473
DOI: 10.1111/ijlh.12879

No abstract available

Publication types

Letter

MeSH terms

Gene Rearrangement*
Humans
Neoplasm, Residual / diagnosis*
Polymerase Chain Reaction / methods*
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Receptor, Fibroblast Growth Factor, Type 1 / genetics*

Substances

FGFR1 protein, human
Receptor, Fibroblast Growth Factor, Type 1

Grants and funding

"Associazione Italiana contro le Leucemie (AIL)-BARI."